Delivery Order SPE2DB22D1017-SPE2DB25FF2PL

Award Date 1/3/25
Potential Completion Date 1/6/25
Potential Value $2.9K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, for the delivery of ACTEMRA 162 MG/0.9 ML SYRINGE 0.9ML medical supplies. The contract, valued at $18,259.84, is a Firm Fixed Price Delivery Order issued by the Defense Logistics Agency (DLA) Troop Support Medical. It has an ultimate completion date of December 31, 2024. The contract is not designated as a set-aside. AmerisourceBergen holds a larger Indefinite...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $9,431.75 and runs through December 6, 2024. It is a firm fixed-price contract for the supply of ACTEMRA 162 MG/0.9 ML SYRINGE 0.9ML, a specialty medication. The contract is not designated as a set-aside. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with...
This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of ACTEMRA 162 MG/0.9 ML syringes, with a ceiling value of $9,681.62 and a completion date of August 21, 2024. The award is for a firm fixed-price delivery order, and the contract type is not set aside. Amerisourcebergen is the prime contractor, and the delivery order is part of a larger Indefinite...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of ACTEMRA 162 MG/0.9 ML syringes. The contract is a Delivery Order with a Firm Fixed Price type and has a ceiling value of $7,442.12. The contract does not have a set-aside designation, and the ultimate completion date is September 5, 2024. Amerisourcebergen is the prime contractor for this award, which is part of a larger Indefinite...
This is a firm fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation. The contract, valued at $1,799.91, is for the delivery of ACTEMRA 162 MG/0.9 ML SYRINGE 0.9ML, a specialty pharmaceutical product. This order was issued under a larger indefinite delivery contract (IDC) held by AmerisourceBergen Drug Corp, valued at up to $999,999,999.00, which serves as the...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the delivery of ACTEMRA 162 MG/0.9 ML SYRINGE 0.9ML. The $16,330.56 firm fixed-price delivery order has an ultimate completion date of December 2, 2024. The contract is not designated as a set-aside. AmerisourceBergen Drug Corp, a major pharmaceutical distributor, holds an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at $999,999,999 through November...
This is a firm fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distributor Amerisourcebergen Corporation. The contract, valued at $1,973.16, is for the delivery of ACTEMRA 162 MG/0.9 ML syringes to support military treatment programs and facilities. The contract has an ultimate completion date of April 10, 2024. Amerisourcebergen Drug Corp holds an Indefinite Delivery Contract (IDC)...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $2,085.48 firm fixed price delivery order is for the supply of ACTEMRA 162 MG/0.9 ML syringes, a specialty medication used to treat certain medical conditions. The contract has a completion date of July 26, 2024 and is not set aside for any small business categories. AmerisourceBergen holds a significant Indefinite Delivery...
This is a firm fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distributor Amerisourcebergen Corporation. The contract, valued at $10,335.30, is for the delivery of ACTEMRA 162 MG/0.9 ML syringes to support military treatment programs and medical facilities. The delivery order has an ultimate completion date of March 27, 2024. Amerisourcebergen Drug Corp holds an...
This federal contract award, valued at $16,473.30, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major supplier of pharmaceutical products and medical supplies to the U.S. government. The contract is for the delivery of ACTEMRA 162 MG/0.9 ML SYRINGE 0.9ML, a pharmaceutical product, with a completion date of April 22, 2024. The contract is a delivery order, with a firm fixed price pricing type. It is not associated with a set-aside program....
  • SPE2DB22D1017
    Indefinite Delivery Contract
  • SPE2DB22D1017-SPE2DB25FF2PL
    Delivery Order

This is a federal contract award by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of ACTEMRA 162 MG/0.9 ML SYRINGE 0.9ML, a medical product, with a ceiling value of $2,877.84. The contract is a Delivery Order with a Firm Fixed Price pricing type, and the ultimate completion date is January 6, 2025. The contract is not designated as a set-aside. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026, which serves as the primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally.

Generated 4/4/25, 9:50 AM